Side-by-side comparison of AI visibility scores, market position, and capabilities
Indian iBuying platform making instant cash offers on homes in Bengaluru; $6.25M from Khosla Ventures applying Opendoor-style liquidity to India's opaque real estate market.
Ivy Homes is a Bengaluru-based proptech company that makes instant cash offers on residential properties in India — using AI and machine learning to provide home valuations and enable sellers to receive immediate liquidity without listing on the open market, staging the property, or waiting through the traditional 60-90 day Indian real estate transaction process. Founded in 2021 and a Y Combinator graduate, Ivy Homes raised $6.25 million led by Khosla Ventures and achieved $907,000 in annual revenue as of March 2024, applying the iBuying model pioneered by Opendoor and Zillow Offers to the Indian market.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.